Secondary Prevention

"Secondary Prevention" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The prevention of recurrences or exacerbations of a disease or complications of its therapy.

Descriptor ID	D055502
MeSH Number(s)	E02.897 N02.421.726.825 N06.850.780.750
Concept/Terms	Secondary Prevention Secondary Prevention Prevention, Secondary Preventions, Secondary Secondary Preventions Secondary Disease Prevention Disease Prevention, Secondary Disease Preventions, Secondary Prevention, Secondary Disease Preventions, Secondary Disease Secondary Disease Preventions Relapse Prevention Relapse Prevention Prevention, Relapse Preventions, Relapse Relapse Preventions Early Therapy Early Therapy Early Therapies Therapies, Early Therapy, Early

Below are MeSH descriptors whose meaning is more general than "Secondary Prevention".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Secondary Prevention [E02.897]
Health Care [N]
Health Care Facilities, Manpower, and Services [N02]
Health Services [N02.421]
Preventive Health Services [N02.421.726]
Secondary Prevention [N02.421.726.825]
Environment and Public Health [N06]
Public Health [N06.850]
Public Health Practice [N06.850.780]
Secondary Prevention [N06.850.780.750]

Below are MeSH descriptors whose meaning is related to "Secondary Prevention".

Below are MeSH descriptors whose meaning is more specific than "Secondary Prevention".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Secondary Prevention" by people in this website by year, and whether "Secondary Prevention" was a major or minor topic of these publications.

Bar chart showing 96 publications over 24 distinct years, with a maximum of 10 publications in 2013 and 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	0	1	1
1999	0	1	1
2000	0	1	1
2001	0	1	1
2002	0	2	2
2003	1	4	5
2004	0	5	5
2005	0	1	1
2006	0	5	5
2007	0	6	6
2008	0	2	2
2009	1	4	5
2010	1	3	4
2011	1	2	3
2012	0	5	5
2013	1	9	10
2014	2	2	4
2015	2	1	3
2016	4	4	8
2017	6	4	10
2018	2	1	3
2019	2	4	6
2020	1	0	1
2021	1	3	4

Below are the most recent publications written about "Secondary Prevention" by people in Profiles.

Anadani M, de Havenon A, Henninger N, Kuohn L, Mac Grory B, Furie KL, Kim AS, Easton JD, Johnston SC, Yaghi S. Antiplatelet Use and Ischemic Stroke Risk in Minor Stroke or Transient Ischemic Attack: A Post Hoc Analysis of the POINT Trial. Stroke. 2021 12; 52(12):e773-e776.

View in: PubMed
Yaghi S, Henninger N, Giles JA, Leon Guerrero C, Mistry E, Liberman AL, Asad D, Liu A, Nagy M, Kaushal A, Azher I, Mac Grory B, Fakhri H, Brown Espaillat K, Pasupuleti H, Martin H, Tan J, Veerasamy M, Esenwa C, Cheng N, Moncrieffe K, Moeini-Naghani I, Siddu M, Scher E, Trivedi T, Furie KL, Keyrouz SG, Nouh A, de Havenon A, Khan M, Smith EE, Gurol ME. Ischaemic stroke on anticoagulation therapy and early recurrence in acute cardioembolic stroke: the IAC study. J Neurol Neurosurg Psychiatry. 2021 10; 92(10):1062-1067.

View in: PubMed
Dalen JE, Goldberg RJ, Waterbrook A, Wylie L, Alpert JS. Should Senior Citizens Take Aspirin Daily to Prevent Heart Attacks or Strokes? Am J Med. 2021 10; 134(10):1185-1188.

View in: PubMed
Patel DA, Flint AJ, Rothschild AJ, Whyte EM, Meyers BS, Mulsant BH, Voineskos AN, Marino P, Alexopoulos GS. Pharmacotherapy Prescriptions for Relapse Prevention of Psychotic Depression After Electroconvulsive Therapy. J Clin Psychopharmacol. 2021 Mar-Apr 01; 41(2):196-199.

View in: PubMed
Levin SR, Farber A, Goodney PP, Schermerhorn ML, Patel VI, Arinze N, Cheng TW, Jones DW, Rybin D, Siracuse JJ. Shunt intention during carotid endarterectomy in the early symptomatic period and perioperative stroke risk. J Vasc Surg. 2020 10; 72(4):1385-1394.e2.

View in: PubMed
Flint AJ, Meyers BS, Rothschild AJ, Whyte EM, Alexopoulos GS, Rudorfer MV, Marino P, Banerjee S, Pollari CD, Wu Y, Voineskos AN, Mulsant BH. Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial. JAMA. 2019 08 20; 322(7):622-631.

View in: PubMed
Cadavid D, Mellion M, Hupperts R, Edwards KR, Calabresi PA, Drulovic J, Giovannoni G, Hartung HP, Arnold DL, Fisher E, Rudick R, Mi S, Chai Y, Li J, Zhang Y, Cheng W, Xu L, Zhu B, Green SM, Chang I, Deykin A, Sheikh SI. Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2019 09; 18(9):845-856.

View in: PubMed
Kurowski A, Pransky G, Punnett L. Impact of a Safe Resident Handling Program in Nursing Homes on Return-to-Work and Re-injury Outcomes Following Work Injury. J Occup Rehabil. 2019 06; 29(2):286-294.

View in: PubMed
Prado G, Svoboda RM, Rigel DS. What's New in Melanoma. Dermatol Clin. 2019 Apr; 37(2):159-168.

View in: PubMed
Singh S, Go AS, Wenger NK, Zoungas S, Gurwitz JH. Reply to: Statins for Primary Prevention in Older Adults. J Am Geriatr Soc. 2019 04; 67(4):857-858.

View in: PubMed

People

Explore

Similar Concepts

Top Journals